Chlamydia trachomatis adhesin-containing vaccine (GlaxoSmithKline)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameChlamydia trachomatis adhesin-containing vaccine (GlaxoSmithKline)

Drug Alias Namechlamydia subunit vaccine (SmithKline Beecham)chlamydia trachomatis vaccine (GSK)chlamydia subunit vaccine (GSK)chlamydia trachomatis vaccine (SmithKline Beecham)

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsChlamydia Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAntex Biologics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGlaxosmithkline Biologicals SA

Active IndicationsN/A

Inactive IndicationsChlamydia Infections

Other Information

ATC CodeN/A